Japan has been in demographic decline for a while. Birth rates well below replacement level are such a big problem that the government has been paying people to have children, a program they’ve expanded to prevent complete demographic collapse.
The government will position the next three years as a period to focus on implementing measures to combat the low birth rate.
The allowance income cap will be removed and eligibility will be extended to all parents with children up to high school age — it is currently offered up to junior high school age.
Families will receive a monthly allowance of ¥15,000 per child ( $95.00 US)for the first and second children up to the age of 2, and ¥10,000 per child from the age of 3 through high school age. For the increase to ¥30,000 (apx. 190 US$) per child through high school age.
It doesn’t sound like a lot but the government will also expand “insurance covering maternity expenses for natural childbirth would be introduced in fiscal 2026.”
One thing they might want to try, if population is a concern is to stop pushing lipid-nano-particle producing mRNA into their citizens. A hint this might be up for consideration comes to us in new research linking three or more injections to a significant rise in Age adjusted mortality.
No significant excess mortality was observed during the first year of the pandemic (2020). However, some excess cancer mortalities were observed in 2021 after mass vaccination with the first and second vaccine doses, and significant excess mortalities were observed for all cancers and some specific types of cancer (including ovarian cancer, leukemia, prostate cancer, lip/oral/pharyngeal cancer, pancreatic cancer, and breast cancer) after mass vaccination with the third dose in 2022.
Correlation is not causation so, “research.”
As of March 2023, 80% of the Japanese population had received their first and second doses, 68% had received their third dose, and 45% had received their fourth dose [1]. Despite these national measures, 33.8 million people had been infected, and 74,500 deaths had been attributed to COVID-19 in Japan by the end of April 2023. Additionally, excess deaths from causes other than COVID-19 have been reported in various countries [2-6], including deaths from cancer [7-10], and Japan is no exception [11,12]. Cancer is the leading cause of death in Japan, accounting for one-fourth of all deaths. Therefore, it is essential to understand the effects of the pandemic on mortality rates of cancer from 2020 to 2022. Age adjustment is necessary for accurate evaluation, especially in diseases such as cancer that tend to occur in elderly adults. Japan has several characteristics that make it ideal for analyzing the impact of the pandemic on cancer mortality rates, including its large population of 123 million, availability of official statistics, and the high 80% accuracy rate of death certificates according to autopsy studies
Japan is officially on its seventh dose and while uptake has declined, they are still on dose seven. That seems, excessive given tis tidbit
Based on the molecular weight of BNT162b2 mRNA (Pfizer-BioNTech), the mRNA content per dose is estimated at 13 trillion molecules and 40 trillion molecules in mRNA-1273 (Moderna) [35,36]. The total number of cells in humans is estimated to be 37.2 trillion [37], making the number of mRNA-LNPs very high, ranging from one-third to the equivalent of the total cell number. After inoculation, the mRNA-LNPs are delivered to various organs, especially the liver, spleen, adrenal gland, ovary, and bone marrow [38]. In one study, vaccine mRNA was detected in the lymph nodes of persons vaccinated with hybridization of a SARS-CoV-2 mRNA vaccine-specific probe 7 to 60 days after the second mRNA-1273 or BNT162b2 dose [39]. Modified mRNA with N1-methyl-pseudouridine could translate a large amount of SARS-CoV-2 spike protein (S-protein) [40]. S-protein emerged on the surface of exosomes in the blood of the vaccinated [41]. Fragments of vaccine-specific recombinant S-protein were found in blood specimens of 50% of vaccine recipients and were still detected three to six months later [42].
And since we’re well into the weeds here.
Because cancer often leads to the activation of coagulation via various mechanisms, one of the major causes of mortality in patients with cancer is cancer-associated thrombosis (CAT) [49-51], manifesting as disseminated intravascular coagulation (DIC) in its most extreme form [52]. Therefore, it is reasonable to assume that the additional thrombus-forming tendency noted with the mRNA-LNP vaccine could be extremely dangerous. The viral and vaccine S-protein of SARS-CoV-2, especially Omicron lineages, having a solid electro-positive potential, could attach to electro-negative glycoconjugates on the surfaces of red blood cells (RBCs), other blood cells, and endothelial cells [53]. The S-protein of SARS-CoV-2 alone has been reported to bind to angiotensin-converting enzyme 2 (ACE2) and activate angiotensin II receptor type 1 (AT1) signal, which promotes interleukin-6 (IL-6) trans-signaling [54], induces vascular wall thickening via activation of the protein kinases [55], impairs mitochondrial function [56], and generates reactive oxygen species (ROS) [57]. A recent study revealed that certain segments of the S-protein can induce the formation of amyloid, a fibrous protein that is insoluble in water. This protein plays a significant role in blood coagulation and fibrinolytic disorders [58]. Anti-spike protein antibodies bind to the S-proteins that emerge on cell surfaces, which triggers autoimmune inflammatory reactions [59-63]. In addition, the injection of LNPs into mice has been reported to cause strong inflammation [64]. All these findings suggest that the COVID-19 mRNA-LNP vaccine poses a risk of thrombosis in individuals with cancer and might explain the excess mortalities after mass vaccination.
Dig in for more scary-sounding stuff, but before I close, Japan relied heavily on the US CDC/FDA approval process for managing their own. And according to the US FDA,
“There are several potential mechanisms by which residual DNA could be oncogenic, including the integration and expression of encoded oncogenes or insertional mutagenesis following DNA integration” [98]. The FDA’s guidelines are essential for Japan because Japan’s special emergency use authorization depended on FDA approval during the COVID-19 pandemic [99]. Recently, some researchers have reported that several lots of Pfizer-BioNTech and Moderna vaccines contain a certain amount of double-stranded DNA fragments from residual plasmid vectors [100,101]. Some of them mentioned that the amount of residual DNA exceeds the regulatory limits for residual DNA set by the FDA. Given these reports and the FDA’s regulatory statement, further investigation is required to determine whether the observed excess cancer deaths following mass vaccination were linked to reported residual DNA in the vaccine.
Have yourself a filed day with that, and this.
These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown.
Research they should have done before even one person rolled up their sleeve.
One more point. Japan has also paying people to move out of Toyoko, which is overcrowded.
Although Tokyo’s population fell for the first time last year– a trend partly attributed to the coronavirus pandemic – policymakers believe more should be done to lower the city’s population density and encourage people to start new lives in “unfashionable” parts of the country that have been hit by ageing, shrinking populations and the migration of younger people to Tokyo, Osaka and other big cities.
Seems like they’ve had a plan all along (7 does?) that runs right into the other problem or demographic decline. Maybe they should pay people to not vaccine their kids too?
